Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
10/2009
10/15/2009WO2009071914A3 Mutant proteins and methods for producing them
10/15/2009WO2009054713A3 Detection of epstein-barr virus (ebv) in nasopharyngeal cancer
10/15/2009WO2009050372A3 Compositions containing lipophosphoramides and use thereof in gene therapy
10/15/2009WO2009044158A3 Inhibitors and uses
10/15/2009WO2009038853A3 Integration of sample storage and sample management for life science
10/15/2009WO2009017902A3 Compositions and methods for identification of subspecies characteristics of mycobacterium tuberculosis
10/15/2009WO2008087561A9 Methods and compositions for modulating the sirna and rna-directed-dna methylation pathways
10/15/2009US20090260110 Method of breeding germinable transgenic broadleaved tree species
10/15/2009US20090260109 Methods of increasing abiotic stress tolerance and/or biomass in plants genterated thereby
10/15/2009US20090260108 Plant producing hyaluronic acid
10/15/2009US20090260107 Coleopteran-Resistant Transgenic Plants and Methods of Their Production
10/15/2009US20090260106 Antifungal polypeptides
10/15/2009US20090260105 UDP-Xylose Synthases (UXS) Polynucleotides, Polypeptides, and Uses Thereof
10/15/2009US20090260104 Novel glyphosate-n-acetyltransferase (gat) genes
10/15/2009US20090260102 Method for the introduction of a heterologous polynucleotide into a mushroom
10/15/2009US20090260101 Heat resistant plants and plant tissues and methods and materials for making and using same
10/15/2009US20090260100 Pea line 08540794
10/15/2009US20090260099 Dry bean line 08550811
10/15/2009US20090260098 Dry bean line 08560863
10/15/2009US20090260097 Soybean Cultivar 05KL115639
10/15/2009US20090260096 Celery Cultivar ADS-18
10/15/2009US20090260095 Gene Marker for Evaluating Genetic Ability for Carcass Weight in Bovine and Method for Evaluating Genetic Ability for Carcass Weight Using the Same
10/15/2009US20090260094 Stearoyl-CoA Desaturase 4 Gene
10/15/2009US20090260093 Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
10/15/2009US20090259027 Human GM-CSF antibodies
10/15/2009US20090259022 Cdna encoding the human alpha2 delta4 calcium channel subunit
10/15/2009US20090259019 Masp-2, a complement fixing enzyme, and uses for it
10/15/2009US20090258935 Hybrid adeno-retroviral vector for the transfection of cells
10/15/2009US20090258934 COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF Nav1.8 GENE
10/15/2009US20090258931 Chimeric oligomeric compounds comprising alternating regions of northern and southern conformational geometry
10/15/2009US20090258930 Double stranded rna structures and constructs, and methods for generating and using the same
10/15/2009US20090258929 Compositions and Methods for Modulating mTOR Signaling
10/15/2009US20090258928 Methods and compositions for diagnosing and modulating human papillomavirus (hpv)
10/15/2009US20090258927 Method for the Modulation of Function of Transcription Factors
10/15/2009US20090258925 Natural antisense and non-coding rna transcripts as drug targets
10/15/2009US20090258832 Cytokines and Cytokine Receptors With Reduced Immunocencity
10/15/2009US20090258827 Transcription Factor Modulator
10/15/2009US20090258826 Pituitary adenylate cyclase activating peptide (PACAP) receptor (VPAC2) agonists and their pharmacological methods of use
10/15/2009US20090258825 HOPM1 Mediated disease resistance to Pseudomonas syringae in Arabidopsis
10/15/2009US20090258819 Reagents and Methods for Smooth Muscle Therapies
10/15/2009US20090258426 Preferred segments of neural thread protein and method of using the same
10/15/2009US20090258425 Gene knock-down by intracellular expression of aptamers
10/15/2009US20090258424 Cellular Delivery of siRNA
10/15/2009US20090258421 Embryonic stem cells and neural progenitor cells derived therefrom
10/15/2009US20090258420 Altered polypeptides, immunoconjugates thereof, and methods related thereto
10/15/2009US20090258416 Polymer micelle complex including nucleic acid
10/15/2009US20090258414 Devices for PCR and for observing nucleic acid hybridization with fluorescence dye during and/or immediately after PCR and using this information for product identification, sequence alteration detection, and quantification; fluorescence resonance energy transfer (fret)
10/15/2009US20090258410 Methods for producing soluble membrane spanning proteins
10/15/2009US20090258409 Purified sr-p70 protein
10/15/2009US20090258400 Mutant Tyrosine Repressor, a Gene Encoding the Same, and a Method for Producing L-Dopa
10/15/2009US20090258396 Crustaceans as production systems for therapeutic proteins
10/15/2009US20090258394 Method for the production of high-level soluble human recombinant interferon alpha in e. coli and vectors useful for such a production
10/15/2009US20090258393 Single chain class i major histocompatibility complexes, constructs encoding same and methods of generating same
10/15/2009US20090258392 Sequence diversity generation in immunoglobulins
10/15/2009US20090258390 Prokaryotic collagen-like proteins and uses thereof
10/15/2009US20090258389 Construction of New Variants of Dextransucrase DSR-S by Genetic Engineering
10/15/2009US20090258380 Perhydrolase Epitopes
10/15/2009US20090258366 pCryptoRNAi
10/15/2009US20090258363 Targeted integration and expression of exogenous nucleic acid sequences
10/15/2009US20090258361 Variant tlr4 nucleic acid and uses thereof
10/15/2009US20090258357 identifying a binding partner to a cytokine receptor common gamma chain like (CRCGCL) polypeptide encoded by a cDNA; for diagnosis and treatment autoimmune disorders
10/15/2009US20090258351 Methods and Reagents for Combined PCR Amplification
10/15/2009US20090258348 Esterases for monitoring protein biosynthesis in vitro
10/15/2009US20090258345 Protein associated with colorectal cancer, polynucleotide including single-nucleotide polymorphism associated with colorectal cancer, microarray and diagnostic kit including the same, and method of diagnosing colorectal cancer using the same
10/15/2009US20090258340 Assay for SARS coronavirus by amplification and detection of the replicase sequence
10/15/2009US20090258036 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3' -utr of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4
10/15/2009US20090258033 HCV E1E2 vaccine compositions
10/15/2009US20090258031 fusion protein comprising polypeptide with a human immunoglobulin (Ig) polypeptide; has an ability to bind CD80 or CD86 or an extracellular domain of either CD80 or CD86, and/or an ability to inhibit a T cell immune response
10/15/2009US20090258026 Anti-notch1 nrr antibodies and methods using same
10/15/2009US20090258023 Tgf-beta superfamily binding proteins and modulation of bone formation and loss
10/15/2009US20090258022 protein comprising signal transduction domain for use in treatment and prevention of nervous system disorders; immunizing a mammal with a protein comprising the sequence of SEQ ID NO:2
10/15/2009US20090258019 Diagnosis of carcinoma using RAIG1 polypeptides
10/15/2009US20090258007 Anti-Perp Antibody
10/15/2009US20090258004 Human blood proteins expressed in monocot seeds
10/15/2009US20090257994 Chimeric immunoreceptor useful in treating human cancers
10/15/2009US20090257981 Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same
10/15/2009US20090257954 Development of a simple animal model for infection by viruses and other obligate intracellular parasites
10/15/2009US20090257952 Engineered Integrin Binding Peptides
10/15/2009CA2758213A1 Anti-atheroma vaccine
10/15/2009CA2758023A1 Commensal bacteria as signal mediators within a mammalian host
10/15/2009CA2721183A1 Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components
10/15/2009CA2721146A1 Cis-acting diversification activator and method for selective diversification of nucleic acids
10/15/2009CA2721117A1 Production of nucleic acid
10/15/2009CA2721088A1 Methods and compositions for accelerating the generation of regulatory t cells ex vivo
10/15/2009CA2720887A1 Inhibitors of stim1 for the treatment of cardiovascular disorders
10/15/2009CA2720827A1 Filamentous fungi with inactivated protease genes for altered protein production
10/15/2009CA2720791A1 Heparanase deficient non-human mammals
10/15/2009CA2720737A1 Plant regulatory elements and uses thereof
10/15/2009CA2720726A1 Heat resistant plants and plant tissues and methods and materials for making and using same
10/15/2009CA2720611A1 Lyophilized dna formulations for enhanced expression of plasmid dna
10/15/2009CA2720610A1 Methods of recombinant production of glycoproteins
10/15/2009CA2720268A1 Production of ospa for lyme disease control
10/15/2009CA2719924A1 Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
10/15/2009CA2719923A1 Expression of heterologous sequences
10/15/2009CA2717772A1 Use of virus-induced gene silencing (vigs) to down-regulate genes in plants
10/15/2009CA2716738A1 Thrombin activator compositions and methods of making and using the same
10/15/2009CA2714997A1 Methods involving ms4a12 and agents targeting ms4a12 for therapy, diagnosis and testing
10/15/2009CA2710398A1 Methods and compositions for targeting polyubiquitin
10/15/2009CA2700510A1 Mutant microorganisms having high ability to produce putrescine and method for producing putrescine using the same
10/14/2009EP2108707A2 Molecular identification of Aspergillus Species